Symphogen raised €100M in a Series D+ round in Feb 2011. The company is based in Ballerup, Denmark. Investors in the round: Essex Woodlands Health Ventures, Novo A, S. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €100M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
